Mark A Lemmon, PhD, FRS
David A. Sackler Professor of Pharmacology; Associate Cancer Center Director for Basic Science, Yale Cancer Center; Co-director, Cancer Biology Institute
Biography
Research & Publications
News
Locations
Appointments
Biography
Mark Lemmon, PhD was appointed the Co-Director of the Cancer Biology Institute and the David A. Sackler Professor of Pharmacology in 2015. Dr. Lemmon returns to Yale, where he completed his PhD in 1993, from the University of Pennsylvania’s Perelman School of Medicine. At UPenn, he was the George W. Raiziss Professor of Biochemistry and Biophysics as well as Chair of the department and an Investigator at the Abramson Family Cancer Research Institute. Dr. Lemmon’s research focuses on the signaling pathways of receptor tyrosine kinases (RTKs), which, when mutated cause cancers and other diseases.
Education & Training
- PhDYale University (1993)
- BAOxford University (Hertford College), Biochemistry (1988)
Departments & Organizations
- Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS)
- Cancer Signaling Networks
- Molecular Medicine, Pharmacology, and Physiology
- Pharmacology
- Primary Faculty
- Yale Cancer Biology Institute
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale CTAP